Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.pastori@uniroma1.it
Daniele Pastori
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
daniele.pastori@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
MOLECULES
2021
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review
CEREBROVASCULAR DISEASES
2021
Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register
BLOOD TRANSFUSION
2021
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis
AUTOIMMUNITY REVIEWS
2021
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome
INTERNAL AND EMERGENCY MEDICINE
2021
The role of antioxidants supplementation in clinical practice: focus on cardiovascular risk factors
ANTIOXIDANTS
2021
Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
2021
Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes
JOURNAL OF CARDIOLOGY
2021
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment
PROGRESS IN CARDIOVASCULAR DISEASES
2021
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus
FRONTIERS IN PHARMACOLOGY
2021
Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2021
Risk scores for death in patients with cancer-related venous thromboembolism. still a long road ahead
THROMBOSIS AND HAEMOSTASIS
2021
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd). A multicenter observational study
NUTRIENTS
2021
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Open issues in the transition from nafld to mafld. the experience of the plinio study
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2021
The challenge of cardiovascular prevention in NAFLD
THE LANCET. GASTROENTEROLOGY & HEPATOLOGY
2021
Antiphospholipid antibodies and heart failure with preserved ejection fraction. The multicenter ATHERO-APS study
JOURNAL OF CLINICAL MEDICINE
2021
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients. asystematic review and metanalysis
THROMBOSIS JOURNAL
2021
Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process
ANTIOXIDANTS
2021
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients
FRONTIERS IN PHARMACOLOGY
2021
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
ERC
LS4
LS4_10
LS7
LS7_10
Keywords
cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis
Progetti di Ricerca
Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma